Neurothera Labs Inc (NTLX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 01/31
(Values in thousands)
| 01-2025 | 01-2024 | 01-2023 | 01-2022 | 01-2021 | |
| Cash Flows From Operating Activities | |||||
| Accounts payable and accrued liabilities | -16 | N/A | N/A | N/A | N/A |
| Other Working Capital | 115 | 34 | -1 | 7 | 0 |
| Other Operating Activity | -239 | -105 | -80 | -117 | -5 |
| Operating Cash Flow | $-141 | $-70 | $-81 | $-110 | $-5 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 0 | 1,326 | 150 |
| Other Financing Activity | 0 | 10 | 0 | 0 | 0 |
| Financing Cash Flow | $0 | $10 | $0 | $1,326 | $150 |
| Beginning Cash Position | 1,220 | 1,281 | 1,361 | 145 | 0 |
| End Cash Position | 1,079 | 1,220 | 1,281 | 1,361 | 145 |
| Net Cash Flow | $-141 | $-60 | $-81 | $1,216 | $145 |
| Free Cash Flow | |||||
| Operating Cash Flow | -141 | -70 | -81 | -110 | -5 |
| Free Cash Flow | -141 | -70 | -81 | -110 | -5 |